Business Description
Applied Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US03828A1016
Description
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 64.22 | |||||
| Equity-to-Asset | -0.31 | |||||
| Debt-to-Equity | -0.05 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -15.11 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 43.8 | |||||
| 3-Year EPS without NRI Growth Rate | 44.1 | |||||
| 3-Year FCF Growth Rate | 43.1 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 17.33 | |||||
| 9-Day RSI | 23.97 | |||||
| 14-Day RSI | 32.62 | |||||
| 6-1 Month Momentum % | 176.72 | |||||
| 12-1 Month Momentum % | 639.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.76 | |||||
| Quick Ratio | 0.76 | |||||
| Cash Ratio | 0.7 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -55.7 | |||||
| Shareholder Yield % | 0.18 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -645.82 | |||||
| Net Margin % | -1198.47 | |||||
| FCF Margin % | -546.94 | |||||
| ROA % | -282.41 | |||||
| ROIC % | -198.48 | |||||
| ROC (Joel Greenblatt) % | -8117.86 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 24.37 | |||||
| EV-to-EBIT | -7.13 | |||||
| EV-to-Forward-EBIT | -6.82 | |||||
| EV-to-EBITDA | -7.17 | |||||
| EV-to-Forward-EBITDA | -6.82 | |||||
| EV-to-Revenue | 46.07 | |||||
| EV-to-Forward-Revenue | 154.11 | |||||
| EV-to-FCF | -8.34 | |||||
| Earnings Yield (Greenblatt) % | -14.03 | |||||
| FCF Yield % | -10.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Applied Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 9.344 | ||
| EPS (TTM) (€) | -1.253 | ||
| Beta | 1.76 | ||
| Volatility % | 203.7 | ||
| 14-Day RSI | 32.62 | ||
| 14-Day ATR (€) | 0.243608 | ||
| 20-Day SMA (€) | 5.18345 | ||
| 12-1 Month Momentum % | 639.63 | ||
| 52-Week Range (€) | 0.975 - 7.27 | ||
| Shares Outstanding (Mil) | 114.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Applied Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Applied Therapeutics Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Applied Therapeutics Inc Frequently Asked Questions
What is Applied Therapeutics Inc(FRA:2UV)'s stock price today?
The current price of FRA:2UV is €4.10. The 52 week high of FRA:2UV is €7.27 and 52 week low is €0.98.
When is next earnings date of Applied Therapeutics Inc(FRA:2UV)?
The next earnings date of Applied Therapeutics Inc(FRA:2UV) is 2024-05-10 Est..
Does Applied Therapeutics Inc(FRA:2UV) pay dividends? If so, how much?
Applied Therapeutics Inc(FRA:2UV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers